865 related articles for article (PubMed ID: 33509065)
1. Acute respiratory distress syndrome and COVID-19 in a child with systemic lupus erythematosus.
Sukhdeo S; Negroponte E; Rajasekhar H; Gaur S; Horton DB; Malhotra A; Moorthy LN
Lupus; 2021 Apr; 30(5):836-839. PubMed ID: 33509065
[TBL] [Abstract][Full Text] [Related]
2. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
He F; Luo Q; Lei M; Fan L; Shao X; Hu K; Qin S; Yu N; Cao J; Yang L
Clin Rheumatol; 2020 Sep; 39(9):2803-2810. PubMed ID: 32725351
[TBL] [Abstract][Full Text] [Related]
3. AntagomiRs: A novel therapeutic strategy for challenging COVID-19 cytokine storm.
Gangemi S; Tonacci A
Cytokine Growth Factor Rev; 2021 Apr; 58():111-113. PubMed ID: 32938545
[TBL] [Abstract][Full Text] [Related]
4. Tocilizumab for the Treatment of COVID-19-Induced Cytokine Storm and Acute Respiratory Distress Syndrome: A Case Series From a Rural Level 1 Trauma Center in Western Pennsylvania.
Suresh K; Figart M; Formeck S; Mehmood T; Abdel Salam M; Bassilly D
J Investig Med High Impact Case Rep; 2021; 9():23247096211019557. PubMed ID: 34105382
[TBL] [Abstract][Full Text] [Related]
5. Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology.
Mantovani Cardoso E; Hundal J; Feterman D; Magaldi J
Clin Rheumatol; 2020 Sep; 39(9):2811-2815. PubMed ID: 32720260
[TBL] [Abstract][Full Text] [Related]
6. The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm.
Chau AS; Weber AG; Maria NI; Narain S; Liu A; Hajizadeh N; Malhotra P; Bloom O; Marder G; Kaplan B
Arthritis Rheumatol; 2021 Jan; 73(1):23-35. PubMed ID: 32929876
[TBL] [Abstract][Full Text] [Related]
7. Acute respiratory distress syndrome associated with macrophage activation syndrome in systemic lupus erythematosus: A case report and literature review.
Chang ES; Yu HH; Wu CE; Chan TM
Medicine (Baltimore); 2022 Feb; 101(5):e28612. PubMed ID: 35119005
[TBL] [Abstract][Full Text] [Related]
8. Early Hemoperfusion for Cytokine Removal May Contribute to Prevention of Intubation in Patients Infected with COVID-19.
Esmaeili Vardanjani A; Ronco C; Rafiei H; Golitaleb M; Pishvaei MH; Mohammadi M
Blood Purif; 2021; 50(2):257-260. PubMed ID: 32594085
[TBL] [Abstract][Full Text] [Related]
9. A Case Report for Using Methylprednisolone for Severe ARDS Caused by SARS-CoV-2 Delta Variant in a Pediatric Patient With Lennox-Gastaut Syndrome.
Park E; You J
J Korean Med Sci; 2022 Mar; 37(10):e82. PubMed ID: 35289141
[TBL] [Abstract][Full Text] [Related]
10. Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions.
Root-Bernstein R
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672738
[TBL] [Abstract][Full Text] [Related]
11. [Proposal for the use of anakinra in acute respiratory distress secondary to COVID-19].
Muñoz-Jiménez A; Rubio-Romero E; Marenco de la Fuente JL
Reumatol Clin (Engl Ed); 2021; 17(6):309-312. PubMed ID: 32482538
[TBL] [Abstract][Full Text] [Related]
12. Nebulized Lidocaine in COVID-19, An Hypothesis.
Ali ZA; El-Mallakh RS
Med Hypotheses; 2020 Nov; 144():109947. PubMed ID: 32505070
[TBL] [Abstract][Full Text] [Related]
13. Antibody response to SARS-CoV-2 in patients receiving glucocorticoids with or without tocilizumab for COVID-19-associated hyperinflammation.
Janssen MTHF; Ramiro S; Landewé RBM; Magro-Checa C; Mostard RLM
Ann Rheum Dis; 2021 Oct; 80(10):1362-1363. PubMed ID: 33958327
[No Abstract] [Full Text] [Related]
14. Repurposed Tocilizumab in Patients with Severe COVID-19.
Tian J; Zhang M; Jin M; Zhang F; Chu Q; Wang X; Chen C; Yue H; Zhang L; Du R; Zhao D; Zeng Z; Zhao Y; Liu K; Wang M; Hu K; Miao X; Zhang H
J Immunol; 2021 Feb; 206(3):599-606. PubMed ID: 33298617
[TBL] [Abstract][Full Text] [Related]
15. A Comprehensive Review of Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome.
Khiali S; Khani E; Entezari-Maleki T
J Clin Pharmacol; 2020 Sep; 60(9):1131-1146. PubMed ID: 32557541
[TBL] [Abstract][Full Text] [Related]
16.
Mardi A; Meidaninikjeh S; Nikfarjam S; Majidi Zolbanin N; Jafari R
Viral Immunol; 2021 Dec; 34(10):679-688. PubMed ID: 34882013
[TBL] [Abstract][Full Text] [Related]
17. Early Cytokine Removal in Critical COVID-19 Patients with Extracorporeal Therapies (HA-380 plus High Volume Hemofiltration) May Prevent Progression of Acute Respiratory Distress Syndrome: Case Report.
Ramírez-Guerrero G; Torres Cifuentes V; Baghetti Hernández R; Villagrán Cortés F; Rojas Doll S; Oliva Alarcón R; Lucero Córdova C; Flores Fernandez P; Garay Coloma O
Blood Purif; 2021; 50(4-5):575-577. PubMed ID: 33264786
[TBL] [Abstract][Full Text] [Related]
18. 20-Year-old female with fever, cough, and dyspnea: Acute lupus pneumonitis during the pandemic of coronavirus disease 2019 (COVID-19).
Yarkan Tuğsal H; İzdeş S; Küçükşahin O
Lupus; 2021 Oct; 30(11):1856-1862. PubMed ID: 34459300
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment with Remdesivir and corticosteroids in a patient with COVID-19-associated pneumonia: A case report.
Gonzales-Zamora JA; Quiroz T; Vega AD
Medwave; 2020 Aug; 20(7):e7998. PubMed ID: 32876623
[TBL] [Abstract][Full Text] [Related]
20. Covid-19 and leptospirosis: Cytokine storm and the use of steroids.
Ittyachen AM
Trop Doct; 2021 Jan; 51(1):128-130. PubMed ID: 33236692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
